Researcher from MacKay Memorial Hospital Describes Findings in Alzheimer Disease (A 52-week, open-label, observational study evaluating tolerability, efficacy and physicians satisfaction of rivastigmine oral solution in Alzheimer's disease in ...)

Source :: Health & Medicine Week. February 28, 2025, 5079
Publication Year :: 2025
Abstract: 2025 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Alzheimer disease. According to news reporting out of [...]

Subjects :: Medical research -- Reports
Medicine, Experimental -- Reports
Diseases -- Taiwan
Physicians -- Reports
Alzheimer's disease -- Reports
Labels -- Reports
Oral medication -- Reports
Health

Tools